Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Phase I study of BNC105P, carboplatin and gemcitabine in partially platinum-sensitive ovarian cancer patients in first or second relapse (ANZGOG-1103).

Lindemann K, Beale PJ, Rossi E, Goh JC, Vaughan MM, Tenney ME, Martyn JK, Sommeijer D, Iglesias JL, Kremmidiotis G, Simpson J, Doolin E, Lavranos TC, Leske A, Veillard AS, Espinoza D, Stockler MR, Rischin D; For ANZGOG and HCRN Collaborative Groups.

Cancer Chemother Pharmacol. 2019 Jan;83(1):97-105. doi: 10.1007/s00280-018-3706-5. Epub 2018 Oct 27.

PMID:
30368585
2.

Patterns of platinum drug use in an acute care setting: a retrospective study.

Armstrong-Gordon E, Gnjidic D, McLachlan AJ, Hosseini B, Grant A, Beale PJ, Wheate NJ.

J Cancer Res Clin Oncol. 2018 Aug;144(8):1561-1568. doi: 10.1007/s00432-018-2669-6. Epub 2018 May 22.

PMID:
29789926
3.

Implementation of a lung cancer multidisciplinary team standardised template for reporting to general practitioners: a mixed-method study.

Rankin NM, Collett GK, Brown CM, Shaw TJ, White KM, Beale PJ, Trevena LJ, Anderiesz C, Barnes DJ.

BMJ Open. 2017 Dec 28;7(12):e018629. doi: 10.1136/bmjopen-2017-018629.

4.

Paragon (ANZGOG-0903): Phase 2 Study of Anastrozole in Women With Estrogen or Progesterone Receptor-Positive Platinum-Resistant or -Refractory Recurrent Ovarian Cancer.

Bonaventura A, O╩╝Connell RL, Mapagu C, Beale PJ, McNally OM, Mileshkin LR, Grant PT, Hadley AM, Goh JCH, Sjoquist KM, Martyn J, DeFazio A, Scurry J, Friedlander ML; Paragon Investigators.

Int J Gynecol Cancer. 2017 Jun;27(5):900-906. doi: 10.1097/IGC.0000000000000978.

PMID:
28498256
5.

The relationship between nutritional status, inflammatory markers and survival in patients with advanced cancer: a prospective cohort study.

Tan CS, Read JA, Phan VH, Beale PJ, Peat JK, Clarke SJ.

Support Care Cancer. 2015 Feb;23(2):385-91. doi: 10.1007/s00520-014-2385-y. Epub 2014 Aug 13.

PMID:
25112562
6.

The median informs the message: accuracy of individualized scenarios for survival time based on oncologists' estimates.

Kiely BE, Martin AJ, Tattersall MH, Nowak AK, Goldstein D, Wilcken NR, Wyld DK, Abdi EA, Glasgow A, Beale PJ, Jefford M, Glare PA, Stockler MR.

J Clin Oncol. 2013 Oct 1;31(28):3565-71. doi: 10.1200/JCO.2012.44.7821. Epub 2013 Sep 3.

PMID:
24002504
7.

Using scenarios to explain life expectancy in advanced cancer: attitudes of people with a cancer experience.

Kiely BE, McCaughan G, Christodoulou S, Beale PJ, Grimison P, Trotman J, Tattersall MH, Stockler MR.

Support Care Cancer. 2013 Feb;21(2):369-76. doi: 10.1007/s00520-012-1526-4. Epub 2012 Jun 21.

PMID:
22717918
8.

Effect of medical Qigong on cognitive function, quality of life, and a biomarker of inflammation in cancer patients: a randomized controlled trial.

Oh B, Butow PN, Mullan BA, Clarke SJ, Beale PJ, Pavlakis N, Lee MS, Rosenthal DS, Larkey L, Vardy J.

Support Care Cancer. 2012 Jun;20(6):1235-42. doi: 10.1007/s00520-011-1209-6. Epub 2011 Jun 19.

PMID:
21688163
9.

Supporting treatment decision making in advanced cancer: a randomized trial of a decision aid for patients with advanced colorectal cancer considering chemotherapy.

Leighl NB, Shepherd HL, Butow PN, Clarke SJ, McJannett M, Beale PJ, Wilcken NR, Moore MJ, Chen EX, Goldstein D, Horvath L, Knox JJ, Krzyzanowska M, Oza AM, Feld R, Hedley D, Xu W, Tattersall MH.

J Clin Oncol. 2011 May 20;29(15):2077-84. doi: 10.1200/JCO.2010.32.0754. Epub 2011 Apr 11.

PMID:
21483008
10.

Randomized cross-over trial comparing inpatient and outpatient administration of high-dose cisplatin.

Cox KM, Goel S, O'Connell RL, Boyer M, Beale PJ, Simes RJ, Stockler MR.

Intern Med J. 2011 Feb;41(2):172-8. doi: 10.1111/j.1445-5994.2010.02201.x.

PMID:
20214694
11.
12.

Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial.

Stockler MR, O'Connell R, Nowak AK, Goldstein D, Turner J, Wilcken NR, Wyld D, Abdi EA, Glasgow A, Beale PJ, Jefford M, Dhillon H, Heritier S, Carter C, Hickie IB, Simes RJ; Zoloft's Effects on Symptoms and survival Time Trial Group.

Lancet Oncol. 2007 Jul;8(7):603-12. Erratum in: Lancet Oncol. 2007 Jul 8;8(7):574.

PMID:
17548243
13.
14.
15.

The fate of platinum(II) and platinum(IV) anti-cancer agents in cancer cells and tumours.

Hall MD, Alderden RA, Zhang M, Beale PJ, Cai Z, Lai B, Stampfl AP, Hambley TW.

J Struct Biol. 2006 Jul;155(1):38-44. Epub 2006 Mar 30.

PMID:
16630726
16.

XANES investigation of the Co oxidation state in solution and in cancer cells treated with Co(III) complexes.

Bonnitcha PD, Hall MD, Underwood CK, Foran GJ, Zhang M, Beale PJ, Hambley TW.

J Inorg Biochem. 2006 May;100(5-6):963-71. Epub 2006 Mar 3.

PMID:
16624414
17.

Disarming the guarded prognosis: predicting survival in newly referred patients with incurable cancer.

Stockler MR, Tattersall MH, Boyer MJ, Clarke SJ, Beale PJ, Simes RJ.

Br J Cancer. 2006 Jan 30;94(2):208-12.

18.

The mechanism of action of platinum(IV) complexes in ovarian cancer cell lines.

Hall MD, Amjadi S, Zhang M, Beale PJ, Hambley TW.

J Inorg Biochem. 2004 Oct;98(10):1614-24.

PMID:
15458824
19.

Battlefield first aid.

Beale PJ, Kerwin-Nye A.

J R Army Med Corps. 2000 Feb;146(1):53. No abstract available.

PMID:
15241987
20.

XANES determination of the platinum oxidation state distribution in cancer cells treated with platinum(IV) anticancer agents.

Hall MD, Foran GJ, Zhang M, Beale PJ, Hambley TW.

J Am Chem Soc. 2003 Jun 25;125(25):7524-5.

PMID:
12812486
21.

Overexpression of BclXL in a human ovarian carcinoma cell line: paradoxic effects on chemosensitivity in vitro versus in vivo.

Rogers PM, Beale PJ, Al-Moundhri M, Boxall F, Patterson L, Valenti M, Raynaud F, Hobbs S, Johnston S, Kelland LR.

Int J Cancer. 2002 Feb 20;97(6):858-63.

22.

Clinical and preclinical pharmacokinetics of raltitrexed.

Clarke SJ, Beale PJ, Rivory LP.

Clin Pharmacokinet. 2000 Dec;39(6):429-43. Review.

PMID:
11192475
23.

Mechanisms of drug resistance to the platinum complex ZD0473 in ovarian cancer cell lines.

Holford J, Beale PJ, Boxall FE, Sharp SY, Kelland LR.

Eur J Cancer. 2000 Oct;36(15):1984-90.

PMID:
11000581
24.

Optimizing the erythromycin breath test for use in cancer patients.

Rivory LP, Slaviero K, Seale JP, Hoskins JM, Boyer M, Beale PJ, Millward MJ, Bishop JF, Clarke SJ.

Clin Cancer Res. 2000 Sep;6(9):3480-5.

25.

BCL-2 family protein expression and platinum drug resistance in ovarian carcinoma.

Beale PJ, Rogers P, Boxall F, Sharp SY, Kelland LR.

Br J Cancer. 2000 Jan;82(2):436-40.

26.

Mini-review: discovery and development of platinum complexes designed to circumvent cisplatin resistance.

Kelland LR, Sharp SY, O'Neill CF, Raynaud FI, Beale PJ, Judson IR.

J Inorg Biochem. 1999 Oct;77(1-2):111-5. Review.

PMID:
10626362
27.

A human capecitabine excretion balance and pharmacokinetic study after administration of a single oral dose of 14C-labelled drug.

Judson IR, Beale PJ, Trigo JM, Aherne W, Crompton T, Jones D, Bush E, Reigner B.

Invest New Drugs. 1999;17(1):49-56.

PMID:
10555122
28.

Bcl-2 family immunohistochemistry.

Kelland LR, Beale PJ.

Methods Mol Med. 1999;28:201-8. doi: 10.1385/1-59259-687-8:201.

PMID:
21374039
29.

Cigarette smoking and duodenal ulcer.

Hull DH, Beale PJ.

Gut. 1985 Dec;26(12):1333-7.

30.

Thrombocytopenia in malaria with immunoglobulin (IgM) changes.

Beale PJ, Cormack JD, Oldrey TB.

Br Med J. 1972 Feb 5;1(5796):345-9.

31.

Late development of a false aneurysm of the common carotid artery.

Beale PJ.

Br J Surg. 1971 Jan;58(1):76-8. No abstract available.

PMID:
5539249
32.

Cerebral malaria.

Beale PJ, Coni NK.

Ann Trop Med Parasitol. 1970 Jun;64(2):243-7. No abstract available.

PMID:
5491875
33.

Megaloblastic anaemia associated with alcoholism.

Beale PJ, Parry ES.

Proc R Soc Med. 1969 Jun;62(6):527-31. No abstract available.

Supplemental Content

Loading ...
Support Center